Cetera Trust Company’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Cetera Trust Company’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,955	Closed	-$390K	–	377
2025 Q1	$390K	Hold	2,955	–	–	0.25%	67
2024 Q4	$247K	Buy	2,955 +435	+17%	+$35.7K	0.16%	135
2024 Q3	$184K	Buy	2,520 +500	+25%	+$37.6K	0.11%	180
2024 Q2	$138K	Buy	+2,020	New	+$140K	0.09%	192

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cetera Trust Company's ITCI Position: Q2 2025 in Review

Cetera Trust Company sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 2,955 shares — an estimated $390K sold.

Cetera Trust Company first reported a position in ITCI in Q2 2024 and held it in 4 quarters. The position peaked at $390K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Cetera Trust Company reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Cetera Trust Company sold 2,955 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $390K.
Cetera Trust Company first reported a position in Intra-Cellular Therapies Inc. in Q2 2024 and held it in 4 quarters.
Cetera Trust Company's Intra-Cellular Therapies Inc. position peaked at $390K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Cetera Trust Company's 13F filing for Q2 2025, filed 6 Aug 2025.